1.10Open1.57Pre Close104 Volume33 Open Interest78.00Strike Price10.57KTurnover49.28%IV2.94%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry1.02Extrinsic Value100Contract SizeAmericanOptions Type-0.3598Delta0.0920Gamma77.38Leverage Ratio-0.2015Theta-0.0030Rho-27.84Eff Leverage0.0309Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet